Low Efficacy of Genetic Tests for the Diagnosis of Primary Lymphedema Prompts Novel Insights into the Underlying Molecular Pathways
Authors:
- Gabriele BonettiGBGabriele Bonetti
- Stefano PaolacciSPStefano Paolacci
- Michele SamajaMSMichele Samaja
- Paolo Enrico MaltesePMPaolo Enrico Maltese
- Sandro MicheliniSMSandro Michelini
- Serena MicheliniSMSerena Michelini
- Silvia MicheliniSMSilvia Michelini
- Maurizio RicciMRMaurizio Ricci
- Marina CestariMCMarina Cestari
- Astrit DautajADAstrit Dautaj
- Maria Chiara MedoriMMMaria Chiara Medori
- Matteo BertelliMBMatteo Bertelli
Open Access
- 3 July 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (13) , 7414
Abstract
Lymphedema is a chronic inflammatory disorder caused by ineffective fluid uptake by the lymphatic system, with effects mainly on the lower limbs. Lymphedema is either primary, when caused by genetic mutations, or secondary, when it follows injury, infection, or surgery. In this study, we aim to assess to what extent the current genetic tests detect genetic variants of lymphedema, and to identify the major molecular pathways that underlie this rather unknown disease. We recruited 147 individuals with a clinical diagnosis of primary lymphedema and used established genetic tests on their blood or saliva specimens. Only 11 of these were positive, while other probands were either negative (63) or inconclusive (73). The low efficacy of such tests calls for greater insight into the underlying mechanisms to increase accuracy. For this purpose, we built a molecular pathways diagram based on a literature analysis (OMIM, Kegg, PubMed, Scopus) of candidate and diagnostic genes. The PI3K/AKT and the RAS/MAPK pathways emerged as primary candidates responsible for lymphedema diagnosis, while the Rho/ROCK pathway appeared less critical. The results of this study suggest the most important pathways involved in the pathogenesis of lymphedema, and outline the most promising diagnostic and candidate genes to diagnose this disease.Keywords
Funding Information
- Provincia Autonoma di Bolzano in the framework of LP 15/2020 (dgp 3174/2021)
This publication has 176 references indexed in Scilit:
- Planar Cell Polarity Protein Celsr1 Regulates Endothelial Adherens Junctions and Directed Cell Rearrangements during Valve MorphogenesisDevelopmental Cell, 2013
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeThe American Journal of Human Genetics, 2012
- Mutations in KIF11 Cause Autosomal-Dominant Microcephaly Variably Associated with Congenital Lymphedema and ChorioretinopathyThe American Journal of Human Genetics, 2012
- Semaphorin signaling in angiogenesis, lymphangiogenesis and cancerCell Research, 2011
- Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothoraxDevelopmental Biology, 2011
- Protein Tyrosine Phosphatase PTPN14 Is a Regulator of Lymphatic Function and Choanal Development in HumansThe American Journal of Human Genetics, 2010
- Heterozygous Germline Mutations in the CBL Tumor-Suppressor Gene Cause a Noonan Syndrome-like PhenotypeThe American Journal of Human Genetics, 2010
- GJC2 Missense Mutations Cause Human LymphedemaThe American Journal of Human Genetics, 2010
- Genomic duplication of PTPN11 is an uncommon cause of Noonan syndromeAmerican Journal of Medical Genetics Part A, 2009
- Integrin-α9 Is Required for Fibronectin Matrix Assembly during Lymphatic Valve MorphogenesisDevelopmental Cell, 2009